Abstract
Tuberculosis (TB) and fungal diseases are opportunistic infections that very often complicate the immunological response in HIV-infected individuals [1-3]. During our studies on novel antimycobacterial and antifungal agents we synthesized a number of new pyrrole derivatives and among them some proved very active against both fungi and mycobacteria. Some others instead were very selective against mycobacteria only. So we pursued a program aimed at individuating the chemical groups or their association, responsible for the particular activity. Moreover, many other pyrroles we synthesized showed to be very active as COX-2 selective inhibitors. In this review we describe our approaches to the synthesis of the pyrrolic structures studied.
Keywords: Pyrrolnitrin, Candida albicans, electrophilic attack, delocalization, mycobacteria
Current Organic Chemistry
Title: New Pyrroles with Potential Antimycobacterial, Antifungal and Selective COX-2 Inhibiting Activities. Synthetic Methodologies
Volume: 11 Issue: 12
Author(s): M. Biava, G. C. Porretta, G. Poce, S. Supino and G. Sleiter
Affiliation:
Keywords: Pyrrolnitrin, Candida albicans, electrophilic attack, delocalization, mycobacteria
Abstract: Tuberculosis (TB) and fungal diseases are opportunistic infections that very often complicate the immunological response in HIV-infected individuals [1-3]. During our studies on novel antimycobacterial and antifungal agents we synthesized a number of new pyrrole derivatives and among them some proved very active against both fungi and mycobacteria. Some others instead were very selective against mycobacteria only. So we pursued a program aimed at individuating the chemical groups or their association, responsible for the particular activity. Moreover, many other pyrroles we synthesized showed to be very active as COX-2 selective inhibitors. In this review we describe our approaches to the synthesis of the pyrrolic structures studied.
Export Options
About this article
Cite this article as:
M. Biava , G. C. Porretta , G. Poce , S. Supino and G. Sleiter , New Pyrroles with Potential Antimycobacterial, Antifungal and Selective COX-2 Inhibiting Activities. Synthetic Methodologies, Current Organic Chemistry 2007; 11 (12) . https://dx.doi.org/10.2174/138527207781369272
DOI https://dx.doi.org/10.2174/138527207781369272 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Microemulsions and Nanoemulsions for Targeted Drug Delivery to the Brain
Current Nanoscience Therapeutic Applications of Nanoemulsion Based Drug Delivery Systems: A Review of Patents in Last Two Decades
Recent Patents on Drug Delivery & Formulation Advances and New Perspectives in Medicinal Chemistry Engineering and Bioinformatics (from IWBBIO 2015)
Current Topics in Medicinal Chemistry Regulation of Cytokine Production by γδ T Cells
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Immunotoxicity and Immunogenicity of Biopharmaceuticals: Design Concepts and Safety Assessment
Current Drug Safety Human Tuberculosis. III. Current and Prospective Approaches in Anti-Tubercular Therapy
Current Medicinal Chemistry Drug Metabolizing Enzymes and Transporters mRNA in Peripheral Blood Mononuclear Cells of Healthy Subjects: Biological Variations and Importance of Preanalytical Steps
Current Drug Metabolism Eco-Friendly and Highly Efficient Synthesis, Including Multigram Synthesis, of Aldehyde Isonicotinoyl Hydrazones Using Sonochemistry
Letters in Organic Chemistry TNFα as Therapeutic Target: New Drugs, More Applications
Current Drug Targets - Inflammation & Allergy From Small to Powerful: The Fragments Universe and its “Chem-Appeal”
Current Medicinal Chemistry The Rhesus Macaque Pediatric SIV Infection Model - A Valuable Tool in Understanding Infant HIV-1 Pathogenesis and for Designing Pediatric HIV-1 Prevention Strategies
Current HIV Research The Role of Oxazolidine Derivatives in the Treatment of Infectious and Chronic Diseases
Current Bioactive Compounds Target Discovery for New Antitubercular Drugs Using a Large Dataset of Growth Inhibitors from PubChem
Infectious Disorders - Drug Targets Health Benefits of Manuka Honey as an Essential Constituent for Tissue Regeneration
Current Drug Metabolism TB Diagnostics – Old and New
Current Respiratory Medicine Reviews Molecular Modeling Databases: A New Way in the Search of Protein Targets for Drug Development
Current Bioinformatics The Neuroprotective Effect of Ginkgo biloba Leaf Extract and its Possible Mechanism
Central Nervous System Agents in Medicinal Chemistry Computational Studies of Molecular Targets Regarding the Adverse Effects of Isoniazid Drug for Tuberculosis
Current Pharmacogenomics and Personalized Medicine Novel 2-(2-Benzylidenehydrazinyl)Benzo[d]Thiazole as Potential Antitubercular Agents
Combinatorial Chemistry & High Throughput Screening Functional Consequences of Immune Cell Adhesion to Endothelial Cells
Current Pharmaceutical Design